Hao Wang

2PUBLICATIONS
20CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 28, 2023
Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignancies.

Francesca Alvarez Calderon, Byong H Kang, Oleksandr Kyrysyuk

|Jul 10, 2021
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.

Yao Wei, Xiaoxin Ren, Phillip M Galbo

Pageof 1